Skip to content

OPEP Therapy in COPD/chronic bronchitis patients with excess mucus

The effectiveness of an Oscillating Positive Expiratory Pressure (OPEP) Therapy on respiratory symptoms in patients with COPD/chronic bronchitis with excess mucus in daily clinical practice”

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27221
Enrollment
96
Registered
2015-12-13
Start date
2015-12-16
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD chronic bronchitis sputum airway clearance COPD chronische bronchitis sputum mucusklaring

Interventions

Patients will be randomly allocated either to the intervention group (using a hand-held mechanical OPEP device, Aerobika) or the control group (using the sham version of the hand-held device).The sham

Sponsors

Martini Hospital Groningen (department of Pulmonary Diseases)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with COPD or bronchitis with excessive mucus will be included in this study. Inclusion criteria - Diagnosis: Patients with COPD or chronic bronchitis. - Aged 40 years or older - Excessive mucus

Exclusion criteria

Exclusion criteria: Exclusion criteria - Patiënts with CF - Patients with bronchiectasis - Patients who used OPEP in the past.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the mean CCQ Total score after 3 months.

Secondary

MeasureTime frame
The secondary endpoints at 3 months are: - mean subdomain scores of the CCQ, respectively symptoms, mental and functional state. - mean Leicester Cough Questionnaire (LCQ) total and domain scores. - St. George’s Respiratory Questionnaire (SGRQ). - A global rating of change in health status and in ability of coughing up sputum after 3 months will be used to evaluate self-perceived change. - Lung function (spirometry, FEV1, FEV1%pred, FVC, FVC%pred). - Exacerbation rate. - Hospitalisation rate for COPD.

Contacts

Public ContactSiebrig Schokker

Longziekten - Martini Ziekenhuis

s.schokker@mzh.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)